Skip to main content

Table 1 Socio-demographic and drug consumption variables associated to self-reported HIV, from drug users in Catalonia, 2012

From: Cross sectional study of factors associated to self-reported blood-borne infections among drug users

 

Total

HIV positive

HIV negative

Bivariate analysisa

Multivariate analysisb

 

n = 512

n = 76 (%)

n = 436 (%)

PR (95 % CI)

PR (95 % CI)

Age, median (IQR)

39 [35–44]

41 [37–45]

36 [32–43]

1 (1.02–1.06)

1.007 (0.98–1.04)

Sex

     

 Men

392 (76.56)

54 (13.78)

338 (86.22)

1

1

 Women

120 (23.44)

22 (18.33)

98 (81.67)

1.32 (0.84–2.08)

1.96 (1.27–3.04)

Country of birth

     

 Spain

462 (90.23)

67 (14.50)

395 (85.50)

1

 

 Other countries

48 (9.38)

8 (16.67)

40 (83.33)

1.15 (0.59–2.26)

 

 Unknown

2 (0.39)

1 (50)

1 (50)

 

Current marital status

     

 Single

275 (53.71)

46 (16.73)

229 (83.27)

1

 

 Married

120 (23.44)

18 (15)

102 (85)

0.89 (0.54–1.47)

 

 Divorced

89 (17.38)

12 (13.48)

77 (86.52)

0.80 (0.44–1.44)

 

 Unknown

28 (5.47)

28 (100)

 

Educational level

     

 Primary education or less

155 (30.27)

28 (18.06)

127 (81.94)

1

 

 Secondary education

203 (39.65)

27 (13.30)

176 (86.70)

0.73 (0.45–1.19)

 

 Undergraduate education

154 (30.08)

21 (13.64)

133 (86.36)

0.75 (0.45–1.26)

 

Current employment status

     

 Current regular job

111 (21.68)

2 (1.80)

109 (98.20)

1

1

 Unemployment

277 (54.1)

38 (13.72)

239 (86.28)

7.75 (1.9–31.59)

5.00 (1.26–19.91)

 Disabled or retired

99 (19.34)

35 (35.35)

64 (64.65)

19.98 (4.93–80.94)

8.92 (2.24–35.60)

 Others, including never has worked and worked at home

25 (4.88)

1 (4)

24 (96)

2.26 (0.21–23.96)

1.71 (0.22–12.99)

Number of years by injecting drug consumption

     

 Non-injecting users

286 (55.86)

8 (2.80)

278 (97.20)

1

1

 Injection for <6 years

58 (11.33)

10 (17.24)

48 (82.76)

6.19 (2.55–15.00)

4.88 (2.08–11.46)

 Injection for 6 to 12 years

27 (5.27)

7 (25.93)

20 (74.07)

9.30 (3.65–23.68)

7.73 (3.08–19.37)

 Injection 13 to 22 years

68 (13.28)

29 (42.65)

39 (57.35)

15.30 (7.32–31.96)

12.10 (5.76–25.41)

 Injection for >22 years

52 (10.16)

18 (34.62)

34 (65.38)

12.42 (5.70–27.05)

7.73 (3.08–19.37)

 Injection for unknown time

21 (4.1)

4 (19.05)

17 (80.95)

6.52 (2.13–19.98)

4.30 (1.19–15.52)

Years after starting drug use, median (IQR)

8.5 [2.4–13.77]

17 [4.80–22.75]

0 [0–4.8]

1.05 (1.03–1.08)

 

Period of onset of the 1st drug use

     

 2001–2012

51 (9.96)

3 (5.88)

48 (94.12)

1

 

 1991–2000

199 (38.87)

15 (7.54)

184 (92.46)

1.28 (0.38–4.24)

 

 1981–1990

195 (38.09)

44 (22.56)

151 (77.44)

3.82 (1.24–11.79)

 

 1953–1980

64 (12.5)

13 (20.31)

51 (79.69)

3.45 (1.04–11.47)

 

 Unknown period

3 (0.59)

1 (33.33)

2 (66.67)

5.67 (0.81–39.46)

 

Heroin use

     

 No

216 (42.19)

5 (2.31)

211 (97.69)

1

 

 Yes

296 (57.81)

71 (23.99)

225 (76.01)

10.46 (4.30–25.46)

 

Prison History

     

 No

393 (76.56)

45 (11.45)

348 (88.55)

1

 

 Yes

119 (23.24)

31 (26.05)

88 (73.95)

3.52 (1.95–6.37)

 
  1. HIV human immunodeficiency virus, IQR interquartile range, PR prevalence ratio, CI confidence intervals
  2. aUnivariate Poisson regression models with robust variance
  3. bMultivariate Poisson regression model included covariates determined to be statistically important on the basis of associations with infection in the univariate analysis (p < 0.2)